These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33333978)

  • 21. Smyd3 open & closed lock mechanism for substrate recruitment: The hinge motion of C-terminal domain inferred from μ-second molecular dynamics simulations.
    Chandramouli B; Silvestri V; Scarno M; Ottini L; Chillemi G
    Biochim Biophys Acta; 2016 Jul; 1860(7):1466-74. PubMed ID: 27085704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.
    McNulty DE; Bonnette WG; Qi H; Wang L; Ho TF; Waszkiewicz A; Kallal LA; Nagarajan RP; Stern M; Quinn AM; Creasy CL; Su DS; Graves AP; Annan RS; Sweitzer SM; Holbert MA
    SLAS Discov; 2018 Jan; 23(1):34-46. PubMed ID: 28957646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase.
    Talibov VO; Fabini E; FitzGerald EA; Tedesco D; Cederfeldt D; Talu MJ; Rachman MM; Mihalic F; Manoni E; Naldi M; Sanese P; Forte G; Lepore Signorile M; Barril X; Simone C; Bartolini M; Dobritzsch D; Del Rio A; Danielson UH
    Chembiochem; 2021 May; 22(9):1597-1608. PubMed ID: 33400854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
    Min W; Hou Z; Zhang F; Xie S; Yuan K; Dong H; Wang L; Qi L; Luo C; Ding H; Yang P
    Bioorg Med Chem; 2020 Apr; 28(7):115372. PubMed ID: 32088124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
    Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMYD3-Mediated H2A.Z.1 Methylation Promotes Cell Cycle and Cancer Proliferation.
    Tsai CH; Chen YJ; Yu CJ; Tzeng SR; Wu IC; Kuo WH; Lin MC; Chan NL; Wu KJ; Teng SC
    Cancer Res; 2016 Oct; 76(20):6043-6053. PubMed ID: 27569210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
    Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
    Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
    Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
    Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells.
    Rodríguez-Fonseca RA; Sixto-López Y; Fragoso-Vázquez MJ; Flores-Mejía R; Cabrera-Pérez LC; Vázquez-Moctezuma I; Rosales-Hernández MC; Bello M; Martínez-Archundia M; Trujillo-Ferrara JG; Becerra-Martínez E; Correa-Basurto J
    Anticancer Agents Med Chem; 2017; 17(10):1441-1454. PubMed ID: 28044941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro.
    Wang SZ; Luo XG; Shen J; Zou JN; Lu YH; Xi T
    BMB Rep; 2008 Apr; 41(4):294-9. PubMed ID: 18452649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinoma.
    Dong SW; Zhang H; Wang BL; Sun P; Wang YG; Zhang P
    Oncol Rep; 2014 Sep; 32(3):1064-70. PubMed ID: 24993551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
    Yoshioka Y; Suzuki T; Matsuo Y; Tsurita G; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
    Cancer Med; 2017 Jul; 6(7):1665-1672. PubMed ID: 28639750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.
    Rajajeyabalachandran G; Kumar S; Murugesan T; Ekambaram S; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
    Expert Opin Ther Targets; 2017 Feb; 21(2):145-157. PubMed ID: 28019723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unveiling the Biochemistry of the Epigenetic Regulator SMYD3.
    Fabini E; Talibov VO; Mihalic F; Naldi M; Bartolini M; Bertucci C; Del Rio A; Danielson UH
    Biochemistry; 2019 Sep; 58(35):3634-3645. PubMed ID: 31389685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
    Thomenius MJ; Totman J; Harvey D; Mitchell LH; Riera TV; Cosmopoulos K; Grassian AR; Klaus C; Foley M; Admirand EA; Jahic H; Majer C; Wigle T; Jacques SL; Gureasko J; Brach D; Lingaraj T; West K; Smith S; Rioux N; Waters NJ; Tang C; Raimondi A; Munchhof M; Mills JE; Ribich S; Porter Scott M; Kuntz KW; Janzen WP; Moyer M; Smith JJ; Chesworth R; Copeland RA; Boriack-Sjodin PA
    PLoS One; 2018; 13(6):e0197372. PubMed ID: 29856759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Silico Identification of Potential Inhibitor Against a Fungal Histone Deacetylase, RPD3 from
    Shanmugam G; Kim T; Jeon J
    Molecules; 2019 May; 24(11):. PubMed ID: 31151320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
    Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
    Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.
    Dai B; Wan W; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2015 Nov; 34(5):2722-30. PubMed ID: 26328527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.